Wave Life Sciences (WVE) Free Cash Flow (2014 - 2026)
Wave Life Sciences (WVE) posted Free Cash Flow of -$60.0 million for Q1 2026, down 77.62% on a QoQ basis from -$33.8 million in Q4 2025, and up 5.08% year-over-year from -$57.1 million in Q1 2025.
Wave Life Sciences (WVE) Free Cash Flow (2014 - 2026) Analysis & Trends
Wave Life Sciences' Free Cash Flow history runs 13 years deep, the most recent figure standing at -$60.0 million for Q1 2026.
- Quarterly Free Cash Flow rose 5.08% year-over-year to -$60.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$185.0 million (down 2.03% YoY) and the FY2025 annual result came in at -$188.2 million, down 23.85% from the prior year.
- Free Cash Flow was -$60.0 million for Q1 2026 at Wave Life Sciences, down from -$33.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $85.0 million in Q1 2023 and bottomed at -$63.2 million in Q1 2025.
- A 5-year average of -$32.3 million and a median of -$34.7 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 377.36% — and 2023, when it surged 312.15%.
- Wave Life Sciences' Free Cash Flow stood at -$33.6 million in 2022, then grew by 0.15% to -$33.6 million in 2023, then sank by 30.18% to -$43.7 million in 2024, then advanced by 22.77% to -$33.8 million in 2025, then tumbled by 77.62% to -$60.0 million in 2026.
- Business Quant data shows WVE's Free Cash Flow at -$60.0 million in Q1 2026, -$33.8 million in Q4 2025, and -$44.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -59.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.99 Mn |
| Mar 31, 2026 | -59.99 Mn |
| Dec 31, 2025 | -33.78 Mn |
| Dec 31, 2025 | -33.78 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Jun 30, 2025 | -46.32 Mn |
| Jun 30, 2025 | -46.32 Mn |
| Mar 31, 2025 | -63.20 Mn |
| Mar 31, 2025 | -63.20 Mn |
| Dec 31, 2024 | -43.73 Mn |
| Dec 31, 2024 | -43.73 Mn |
| Sep 30, 2024 | -46.86 Mn |
| Sep 30, 2024 | -46.86 Mn |
| Jun 30, 2024 | -27.52 Mn |
| Jun 30, 2024 | -27.52 Mn |
| Mar 31, 2024 | -33.85 Mn |
| Mar 31, 2024 | -33.85 Mn |
| Dec 31, 2023 | -33.60 Mn |
| Dec 31, 2023 | -33.60 Mn |